Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Self-reported hepatitis C virus antibody status and risk behavior in young injectors.

Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, Hudson S, Garfein RS.

Public Health Rep. 2006 Nov-Dec;121(6):710-9.

2.

Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.

Boodram B, Golub ET, Ouellet LJ.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):136-45. doi: 10.1016/j.drugalcdep.2010.04.003. Epub 2010 May 15.

PMID:
20472373
3.

HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.

Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G; National HIV Behavioral Surveillance System Study Group..

MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.

4.

The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.

Kwiatkowski CF, Fortuin Corsi K, Booth RE.

Addiction. 2002 Oct;97(10):1289-94.

PMID:
12359033
5.

High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities.

Campbell JV, Hagan H, Latka MH, Garfein RS, Golub ET, Coady MH, Thomas DL, Strathdee SA; STRIVE Project..

Drug Alcohol Depend. 2006 Feb 28;81(3):259-65. Epub 2005 Aug 29.

7.

Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.

Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman SR.

Drug Alcohol Depend. 2009 Apr 1;101(1-2):88-91. doi: 10.1016/j.drugalcdep.2008.11.007. Epub 2008 Dec 23.

PMID:
19108958
8.

A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.

Sarkar S, Panda S, Sarkar K, Hangzo CZ, Bijaya L, Singh NY, Das N, Agarwal A, Chatterjee A, Deb BC, et al.

Indian J Public Health. 1995 Jul-Sep;39(3):86-92.

PMID:
8690497
9.

Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs.

Buffington J, Murray PJ, Schlanger K, Shih L, Badsgard T, Hennessy RR, Wood R, Weisfuse IB, Gunn RA.

Public Health Rep. 2007;122 Suppl 2:63-7.

10.

Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.

Rhodes T, Platt L, Judd A, Mikhailova LA, Sarang A, Wallis N, Alpatova T, Hickman M, Parry JV.

Int J STD AIDS. 2005 Nov;16(11):749-54.

PMID:
16303071
11.

Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.

Panda S, Roy T, Pahari S, Mehraa J, Sharma N, Singh G, Singh J, Joseph F, Singh S, Sharma NM.

Int J STD AIDS. 2014 Jul;25(8):596-606. doi: 10.1177/0956462413515659. Epub 2013 Dec 18.

PMID:
24352120
12.

Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K.

Addiction. 2010 Jul;105(7):1254-64. doi: 10.1111/j.1360-0443.2010.02949.x. Epub 2010 May 14.

13.

HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.

Miller M, Mella I, Moi H, Eskild A.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):373-9.

PMID:
12843749
14.

Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).

Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, Strathdee SA, Williams IT, Bailey SL, Hagan H, Golub ET, Kerndt P, Hanson DL, Latka MH; DUIT Study Team..

Drug Alcohol Depend. 2007 Nov;91 Suppl 1:S4-17. Epub 2007 Jun 19.

PMID:
17582705
15.
16.

Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.

Maher L, Chant K, Jalaludin B, Sargent P.

J Gastroenterol Hepatol. 2004 Oct;19(10):1114-20.

PMID:
15377287
17.

Risk of hepatitis C infection among injection drug users in Mizoram, India.

Chelleng PK, Borkakoty BJ, Chetia M, Das HK, Mahanta J.

Indian J Med Res. 2008 Nov;128(5):640-6.

PMID:
19179686
18.

Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland.

Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA.

Clin Infect Dis. 2002 Oct 1;35(7):783-8. Epub 2002 Sep 3.

PMID:
12228813
19.

"To share or not to share?" Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants.

Smith BD, Jewett A, Burt RD, Zibbell JE, Yartel AK, DiNenno E.

J Infect Dis. 2013 Dec 15;208(12):1934-42. doi: 10.1093/infdis/jit520. Epub 2013 Oct 16.

PMID:
24136794
20.

The association between alcohol use and hepatitis C status among injecting drug users in Glasgow.

O'Leary MC, Hutchinson SJ, Allen E, Palmateer N, Cameron S, Taylor A, Goldberg DJ.

Drug Alcohol Depend. 2012 Jun 1;123(1-3):180-9. doi: 10.1016/j.drugalcdep.2011.11.008. Epub 2011 Dec 2.

PMID:
22137645

Supplemental Content

Support Center